Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: Critical role for serotonin-induced smooth muscle hyperplasia

Circulation

Volumn 113, Issue 15, 2006, Pages 1857-1864

  Eddahibi, Saadia ^a,e   Guignabert, Christophe ^a   Barlier Mur, Anne Marie ^a   Dewachter, Laurence ^a   Fadel, Elie ^d   Dartevelle, Philippe ^d   Humbert, Marc ^b,c   Simonneau, Gerald ^c   Hanoun, Naïma ^b   Saurini, Françoise ^b   Hamon, Michel ^b,c   Adnot, Serge ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

^d CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^e INSERM   (France)

Author keywords

Endothelial cells; Hypertension, pulmonary; Serotonin; Tryptophan hydroxylase

Indexed keywords

5 HYDROXYTRYPTOPHAN; ENDOTHELIN RECEPTOR ANTAGONIST; FENCLONINE; FLUOXETINE; GROWTH FACTOR; SEROTONIN; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE; SLC6A4 PROTEIN, HUMAN;

ADULT; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; INTIMA; LUNG BLOOD VESSEL; MALE; MITOGENESIS; PARACRINE SIGNALING; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SMOOTH MUSCLE FIBER; SYNTHESIS; TPH1 GENE; AGED; BIOSYNTHESIS; CASE CONTROL STUDY; CELL CULTURE; CELL DIVISION; CHEMISTRY; CULTURE MEDIUM; DRUG EFFECT; ENZYMOLOGY; LUNG; METABOLISM; MIDDLE AGED; PATHOLOGY; PULMONARY ARTERY; SMOOTH MUSCLE;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; ENDOTHELIAL CELLS; FEMALE; HUMANS; HYPERPLASIA; HYPERTENSION, PULMONARY; LUNG; MALE; MIDDLE AGED; MUSCLE, SMOOTH; MYOCYTES, SMOOTH MUSCLE; PULMONARY ARTERY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRYPTOPHAN HYDROXYLASE;

EID: 33646201514     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.591321     Document Type: Article

References (33)

1. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med. 2004;351:1655-1665.
2. Adnot S. Lessons learned from cancer may help in the treatment of pulmonary hypertension. J Clin Invest. 2005;115:1461-1463.
3. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res. 2005;97:512-523.
4. Folkman J, D'Amore PA. Blood vessel formation: what is its molecular basis? Cell. 1996;87:1153-1155.
5. Fanburg B, Lee S-L. A new role for an old molecule: serotonin as a mitogen. Am J Physiol. 1997;272:L795-L806.
6. Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, Adnot S. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest. 2001;108:1141-1150.
7. Marcos E, Fadel E, Sanchez O, Humbert M, Dartevelle P, Simonneau G, Hamon M, Adnot S, Eddahibi S. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Circ Res. 2004;94:1263-1270.
8. Launay JM, Herve P, Peoc'h K, Tournois C, Callebert J, Nebigil CG, Etienne N, Drouet L, Humbert M, Simonneau G, Maroteaux L. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med. 2002;8:1129-1135.
9. Morrell NW, Yang X, Upton PD, Jourdan KB, Morgan N, Sheares KK, Trembath RC. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins. Circulation. 2001;104:790-795.
10. Yu Y, Fantozzi I, Remillard CV, Landsberg JW, Kunichika N, Platoshyn O, Tigno DD, Thistlethwaite PA, Rubin LJ, Yuan JX. Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension. Proc Natl Acad Sci U S A. 2004;101:13861-13866.
11. Lee SL, Wang WW, Moore BJ, Fanburg BL. Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture. Circ Res. 1991;68:1362-1368.
12. Eddahibi S, Fabre V, Boni C, Martres MP, Raffestin B, Hamon M, Adnot S. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells: relationship with the mitogenic action of serotonin. Circ Res. 1999;84:329-336.
13. Davie N, Haleen SJ, Upton PD, Polak JM, Yacoub MH, Morrell NW, Wharton J. ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am. J Respir Crit Care Med. 2002;165:398-405.
14. Hewett PW, Murray JC. Human microvessel endothelial cells: isolation, culture and characterization. In Vitro Cell Dev Biol Anim. 1993;29A:823-830.
15. Koe B, Weissman A. p-Chlorophenylalanine: a specific depletor of brain serotonin. J Pharmacol Exp Ther. 1966;154:499-516.
16. Hamon M, Bourgoin S, Youdim M. Tryptophan hydroxylation in the central nervous system and other tissues. In: Youdim MBH, ed. Amino Acid Hydrolases and Mental Disease. London, UK: John Wiley Ltd; 1979:234-297.
17. Lepetit P, Touret M, Grange E, Gay N, Bobillier P. Inhibition of methionine incorporation into brain proteins after the systemic administration of p-chlorophenylalanine and L-5-hydroxytryptophan. Eur J Pharmacol. 1991;209:207-212.
18. Hamon M, Fattaccini C, Adrien J, Gallissot M, Martin P, Gozlan H. Alterations in central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties. J Pharmacol Exp Ther. 1988;246:745-752.
19. Tappaz ML, Pujol JF. Estimation of the rate of tryptophan hydroxylation in vivo: a sensitive microassay in discrete rat brain nuclei. J Neurochem. 1980;34:933-940.
20. Boularand S, Darmon MC, Mallet J. The human tryptophan hydroxylase gene: an unusual splicing complexity in the 5′-untranslated region. J Biol Chem. 1995;270:3748-3756.
21. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, Bader M. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 2003;299:76.
22. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 1995;333:214-221.
23. Tuder RM, Cool CD, Geraci MW, Wang J, Abman SH, Wright L, Badesch D, Voelkel NF. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Med. 1999;159:1925-1932.
24. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993;328:1732-1739.
25. Hanahan D. Signaling vascular morphogenesis and maintenance. Science. 1997;277:48-50.
26. Sullivan CC, Du L, Chu D, Cho AJ, Kido M, Wolf PL, Jamieson SW, Thistlethwaite PA. Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway. Proc Natl Acad Sci U S A. 2003;100:12331-12336.
27. Jacobs B, Azmitia E. Structure and function of the brain serotonin system. Physiol Rev. 1992;72:165-229.
28. Nemecek GM, Cougghlin SR, Handley DA, Moskowitz MA. Stimulation of aortic smooth muscle cells mitogenesis by serotonin. Proc Natl Acad Sci U S A. 1986;83:674-678.
29. Gershon MD. Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther. 1999;13(suppl 2):15-30.
30. Herve P, Drouet L, Dosquet C, Launay JM, Rain B, Simonneau G, Caen J, Duroux P. Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am J Med. 1990;89:117-120.
31. Abenhaim L, Monde Y, Brenot F, Rich S, Benichou J, Kurz X, Higenbottam T, Oakley C, Wouters E, Aubier M, Simonneau G, Begaud B. Appetite-suppressant drugs and the risk of primary pulmonary hypertension: International Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996;335:609-616.
32. Sato K, Webb S, Tucker A, Rabinovitch M, O'Brien RF, McMurtry JF, Stelzner TJ. Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat. Am Rev Respir Dis. 1992;145:793-797.
33. Louis W. Primary pulmonary hypertension and anorectic drugs. N Engl J Med. 1999;340:482-483.